These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8524844)

  • 1. The specificity of the transforming growth factor beta receptor kinases determined by a spatially addressable peptide library.
    Luo K; Zhou P; Lodish HF
    Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11761-5. PubMed ID: 8524844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The p21(RAS) farnesyltransferase alpha subunit in TGF-beta and activin signaling.
    Wang T; Danielson PD; Li BY; Shah PC; Kim SD; Donahoe PK
    Science; 1996 Feb; 271(5252):1120-2. PubMed ID: 8599089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signaling via hetero-oligomeric complexes of type I and type II serine/threonine kinase receptors.
    ten Dijke P; Miyazono K; Heldin CH
    Curr Opin Cell Biol; 1996 Apr; 8(2):139-45. PubMed ID: 8791413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A kinase subdomain of transforming growth factor-beta (TGF-beta) type I receptor determines the TGF-beta intracellular signaling specificity.
    Feng XH; Derynck R
    EMBO J; 1997 Jul; 16(13):3912-23. PubMed ID: 9233801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GS domain mutations that constitutively activate T beta R-I, the downstream signaling component in the TGF-beta receptor complex.
    Wieser R; Wrana JL; Massagué J
    EMBO J; 1995 May; 14(10):2199-208. PubMed ID: 7774578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive and negative regulation of type II TGF-beta receptor signal transduction by autophosphorylation on multiple serine residues.
    Luo K; Lodish HF
    EMBO J; 1997 Apr; 16(8):1970-81. PubMed ID: 9155023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The type II transforming growth factor-beta receptor autophosphorylates not only on serine and threonine but also on tyrosine residues.
    Lawler S; Feng XH; Chen RH; Maruoka EM; Turck CW; Griswold-Prenner I; Derynck R
    J Biol Chem; 1997 Jun; 272(23):14850-9. PubMed ID: 9169454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunophilin FKBP12 functions as a common inhibitor of the TGF beta family type I receptors.
    Wang T; Li BY; Danielson PD; Shah PC; Rockwell S; Lechleider RJ; Martin J; Manganaro T; Donahoe PK
    Cell; 1996 Aug; 86(3):435-44. PubMed ID: 8756725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinase activity of the type V transforming growth factor beta receptor.
    Liu Q; Huang SS; Huang JS
    J Biol Chem; 1994 Mar; 269(12):9221-6. PubMed ID: 8132659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta type-II receptor signalling: intrinsic/associated casein kinase activity, receptor interactions and functional effects of blocking antibodies.
    Hall FL; Benya PD; Padilla SR; Carbonaro-Hall D; Williams R; Buckley S; Warburton D
    Biochem J; 1996 May; 316 ( Pt 1)(Pt 1):303-10. PubMed ID: 8645222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of inactivation of TGF-beta receptors during carcinogenesis.
    Kim SJ; Im YH; Markowitz SD; Bang YJ
    Cytokine Growth Factor Rev; 2000; 11(1-2):159-68. PubMed ID: 10708963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of a serine/threonine kinase signaling pathway by transforming growth factor type beta.
    Atfi A; Lepage K; Allard P; Chapdelaine A; Chevalier S
    Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12110-4. PubMed ID: 8618854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of the transforming growth factor beta 1 and its type I and II receptors in the development of a pulmonary adenocarcinoma: results of an immunohistochemical study.
    Takanami I; Tanaka F; Hashizume T; Kodaira S
    J Surg Oncol; 1997 Apr; 64(4):262-7. PubMed ID: 9142180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of transforming growth factor-beta receptors I and II is seen in lesional but not non-lesional psoriatic epidermis.
    Leivo T; Leivo I; Kariniemi AL; Keski-Oja J; Virtanen I
    Br J Dermatol; 1998 Jan; 138(1):57-62. PubMed ID: 9536223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conserved role for 14-3-3epsilon downstream of type I TGFbeta receptors.
    McGonigle S; Beall MJ; Feeney EL; Pearce EJ
    FEBS Lett; 2001 Feb; 490(1-2):65-9. PubMed ID: 11172812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor expression modulates the specificity of transforming growth factor-beta signaling pathways.
    Murakami M; Kawachi H; Ogawa K; Nishino Y; Funaba M
    Genes Cells; 2009 Apr; 14(4):469-82. PubMed ID: 19335617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The GS domain of the transforming growth factor-beta type I receptor is important in signal transduction.
    Franzén P; Heldin CH; Miyazono K
    Biochem Biophys Res Commun; 1995 Feb; 207(2):682-9. PubMed ID: 7864860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-β signalling: role and consequences of Smad linker region phosphorylation.
    Kamato D; Burch ML; Piva TJ; Rezaei HB; Rostam MA; Xu S; Zheng W; Little PJ; Osman N
    Cell Signal; 2013 Oct; 25(10):2017-24. PubMed ID: 23770288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a functional site on the type I TGF-beta receptor by mutational analysis of its ectodomain.
    Guimond A; Sulea T; Zwaagstra JC; Ekiel I; O'Connor-McCourt MD
    FEBS Lett; 2002 Feb; 513(2-3):147-52. PubMed ID: 11904140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Theme and variations: juxtamembrane regulation of receptor protein kinases.
    Hubbard SR
    Mol Cell; 2001 Sep; 8(3):481-2. PubMed ID: 11583608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.